IP Patent Data SequenceBase specializes in providing patent sequence information and USPTO data through USGENE and the STN portal, offering a targeted dataset for life-science IP professionals. Sales opportunity: position expanded access or customized subscription bundles to legal teams and corporate IP departments seeking comprehensive patent sequence searches.

Expansion Potential Acquired by Clarivate in 2019, SequenceBase sits within a larger analytics ecosystem that can be cross-sold with patent analytics, case law, and IP risk assessment tools. Sales angle: bundle sequence data with broader IP analytics to create integrated research workflows for biotech and pharmaceutical companies.

Affordability Gap Reported revenue under $1M with a lean team suggests high value-per-seat tools but potential price sensitivity. Sales strategy: offer scalable pricing tiers, trial access, and a plug-and-play integration with existing in-house platforms to reduce procurement barriers for mid-market biotech firms.

Tech Stack Fit Utilizes AWS, Snowplow, TypeScript and modern web technologies, enabling robust data delivery and analytics pipelines. Sales tactic: emphasize seamless cloud-based delivery, API access, and customizable data downloads that fit into customers’ data science and compliance workflows.

Market Positioning Operates in a niche of life-science IP data with interoperability to STN International, targeting biotech, pharma, legal, and academic sectors. Sales angle: highlight competitive differentiation through non-redundant, searchable USPTO sequence data and specialized BLAST search capabilities to accelerate patent landscape analyses.